Interceptor Plus 57 mg (Praziquantel TABLET) 57 MG

Interceptor Plus 57 mg is a veterinary medication containing praziquantel, used to treat parasitic infections in pets. This oral tablet helps manage internal parasites, ensuring your pet's health and well-being.

Strength

57 MG

Pack Size

1/6/12

Manufacturer / TM Owner

ELANCO CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Interceptor Plus 57 mg is primarily used for the treatment and prevention of parasitic infections in pets. It is effective against various internal parasites, including tapeworms and other intestinal worms. Pet owners often use this medication as part of a routine parasite control program to maintain their pet's health.

Side Effects

Interceptor Plus 57 mg works by targeting and eliminating parasites within the gastrointestinal tract. Many pet owners observe improved health and reduced symptoms of parasitic infections after administering this medication. It is designed to be gentle on the pet's system while effectively addressing the underlying issue.

Precautions & Warnings

Always follow the guidance of a veterinarian when administering Interceptor Plus 57 mg. Ensure the medication is stored properly and kept out of reach of children and pets. Monitor your pet for any adverse reactions and consult a veterinarian if concerns arise.

Avoid Interactions

Interceptor Plus 57 mg may interact with other medications, so it's important to inform your veterinarian about any other treatments your pet is receiving. Avoid administering this medication with other antiparasitic treatments unless directed by a professional.

Frequently Asked Questions

Interceptor Plus 57 mg is used to treat and prevent parasitic infections in pets, including tapeworms and other intestinal worms.

Interceptor Plus 57 mg is an oral tablet that should be administered as directed by your veterinarian. Follow the recommended dosage and administration guidelines.

Common side effects may include mild gastrointestinal upset. Monitor your pet for any adverse reactions and consult a veterinarian if necessary.

It's important to consult your veterinarian before using Interceptor Plus 57 mg with other medications to avoid potential interactions.

Store Interceptor Plus 57 mg in a cool, dry place, out of reach of children and pets, unless otherwise directed by your veterinarian.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.